Impact of BCR-ABL1 Transcript Type on Outcome in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors: A Pairwise and Bayesian Network Meta-Analysis

PURPOSE: To evaluate the impact of BCR-ABL1 transcript type on outcome in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs). METHODS: PubMed, Embase and Cochrane library were systematically searched for relevant studies. Outcomes assessed were: major molecular re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kangkang, Ruan, Yingying, Tian, Kewei, Xiong, Peisheng, Xia, Nan, Li, Jin, Huang, Wen, Cao, Feiyan, Chen, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867088/
https://www.ncbi.nlm.nih.gov/pubmed/35223524
http://dx.doi.org/10.3389/fonc.2022.841546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867088/
https://www.ncbi.nlm.nih.gov/pubmed/35223524
http://dx.doi.org/10.3389/fonc.2022.841546

Ejemplares similares